Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

168 Results

  • Includes a Live Web Event on 12/12/2024 at 8:00 AM (PST)

    Live symposium featuring various aspects of healthcare-associated infections and sepsis.

    Description: 

    Date: December 12, 2024

    Time: 10:00 am - 3:00 pm ET / 7:00 am - 12:00 pm PT

    Healthcare-associated infections (HAIs) are the most common challenge in hospital settings, posing significant risks for both patients and healthcare providers. According to the Centers for Disease Control and Prevention (CDC), one in every 31 hospital patients contracts at least one HAI daily, leading to substantial financial burdens for healthcare organizations. The risk of HAIs escalating into sepsis underscores the critical need for effective prevention measures.

    Healthcare professionals must prioritize the identification and implementation of strategies to improve performance and outcomes in preventing HAIs and sepsis across all departments and specialties.

    Sepsis Alliance is hosting the 2024 Sepsis Alliance Symposium: Healthcare-Associated Infections to continue our mission and further the idea that infection prevention is sepsis prevention. This engaging virtual event will take place on December 12, 2024, and will delve into essential topics surrounding HAIs. Attendees will gain access to cutting-edge clinical insights and the latest recommendations for preventing and treating infections. This half-day symposium aims to highlight the importance of HAI prevention in clinical practice, ultimately striving to improve patient outcomes and reduce the incidence of sepsis.

    Topics covered will include:

    • Healthcare-associated C-Diff
    • Role of gut microbiome in HAI prevention
    • Catheter-associated urinary tract infections (CAUTI)
    • Central line-associated bloodstream infections (CLABSI)
    • HAI surveillance: Past, present, and future
    • Preventing healthcare-associated infections in surgical patients

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Demonstrate increased knowledge relating to maintaining a compliant and effective infection prevention and control program in the healthcare setting;
    • Describe examples of infection prevention and control evidence-based best practices and recommendations;
    • Propose innovative approaches, protocols, tools and documentation for limiting healthcare-associated infections.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Symposium Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this symposium by the following sponsors:

    image
    image
    image

     

    image
    Kidney Care  

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

    Welcome & Opening Remarks

    Time: 10:00 - 10:10 AM ET


    Session 1

    Time: 10:10 - 10:40 AM ET

    More information to come.


    Session 2

    Time: 10:40 - 11:10 AM ET

    More information to come.


    Sponsor Session 1
    BD Sponsored Session: Clinical Burden of Hospital Onset Bacteremia and Fungemia (HOB)

    Time: 11:25 - 11:40 AM ET

    Hospital Onset Bacteremia & Fungemia (HOB) is a new metric proposed by the CDC for National Healthcare Safety Network (NHSN) volunteer reporting. This sponsored presentation will delve into recent research papers that elucidate the differences between HOB and Central Line-associated Bloodstream Infection (CLABSI), the impact of urine sources on Catheter Associated Urinary Tract Infections (CAUTI) and non-catheter Hospital Onset UTIs contributing to HOB, the burden of Surgical Site Infections (SSI) associated with HOB, and the overall clinical and health economic significance of HOB.


    Session 3

    Time: 11:40 AM - 12:10 PM ET

    More information to come.


    Sponsor Session 2
    BD Sponsored Session: The Impact of Drug-Resistant Infections in the Cancer Community

    Time: 12:10 - 12:40 PM ET

    Nearly 100 years ago, scientists handed the world a new miracle drug: antibiotics. This revolutionized healthcare, improving the length and quality of our lifespans. Modern medicine has been built on the bedrock of being capable of controlling infections while treating aggressive disease. We stand on the precipice of losing this ability, as antimicrobial resistance (AMR) threatens to overwhelm our antibiotic and antifungal supply. Nowhere is this more concerning than in the cancer community.  This sponsored presentation will review current literature analyzing the impact of AMR on the cancer community and will provide an overview of suggested actions we can take to reduce the risk of drug-resistant infections.


    Session 4

    Time: 12:40 - 1:10 PM ET

    More information to come.


    Session 5
    Compendium of Strategies to Prevent CAUTIs: 2022 Updates

    Time: 1:25 - 1:55 PM ET

    This presentation offers a comprehensive overview of the latest methods to prevent catheter-associated urinary tract infections (CAUTIs). Recent changes and additions to the CAUTI Compendium, providing participants with updated strategies to minimize infection risks, will be covered. Attendees will also learn how to incorporate diagnostic and antimicrobial stewardship into their CAUTI prevention practices effectively. Additionally, the differences between infectious and noninfectious harms linked to CAUTIs will be explored, equipping healthcare professionals with the knowledge to improve patient outcomes. 


    Sponsor Session 3
    CorMedix Sponsored Session: Reducing the Risk of Catheter Related Blood Stream Infections in Hemodialysis Patients

    Time: 1:55 - 2:10 PM ET

    In this sponsored session, learn about the risks of catheter related blood stream infections in hemodialysis patients. Opportunities for prevention will also be discussed, including the clinical data for a recent FDA-approved catheter lock solution. The presenter will cover ways for healthcare teams to work together to improve patient outcomes.


    Sponsor Session 4
    Wolters Kluwer Sponsored Session

    Time: 2:10 - 2:25 PM ET

    More information to come.


    Session 6
    Strategies for Preventing C. difficile Infections in Hospitals

    Time: 2:25 - 2:55 PM ET

    This presentation will explore the current landscape of C. difficile infections in U.S. hospitals, emphasizing the urgency of addressing this persistent healthcare challenge. Attendees will gain insights into the most effective infection prevention strategies, including well-established and emerging practices. The session will also address the complexities and ongoing debates around additional preventative measures, offering a comprehensive understanding of how hospitals can enhance patient safety and reduce infection rates.


    Closing Remarks: Key Takeaways

    Time: 2:55 - 3:00 PM ET



    Time (ET)Session TitlePresenter
    10:00-10:10Welcome and Opening Remarks
    10:10-10:40Session 1: More information to come
    10:40-11:10Session 2: More information to come
    11:10-11:25Break
    11:25-11:40BD Sponsored Session: Clinical Burden of Hospital Onset Bacteremia and Fungemia (HOB)Kalvin Yu, MD, FIDSA
    Vice President of Medical Affairs, North America, BD
    Samantha Bastow, PharmD, MBA Associate Director, Clinical Integration, Medical Affairs, US Region, BD
    11:40-12:10Session 3: More information to come

    12:10-12:40BD Sponsored Session: The Impact of Drug-Resistant Infections in the Cancer CommunityDiane Flayhart, MS
    Director, Global Public Health
    BD
    12:40-1:10Session 4: More information to come
    1:10-1:25Break

    1:25-1:55Session 5: Compendium of Strategies to Prevent CAUTIs: 2022 UpdatesPayal Patel, MD, MPH, FIDSA
    System-Wide Medical Director of Antimicrobial Stewardship, Associate Professor  
    Intermountain Health
    1:55-2:10
    CorMedix Sponsored Session: 
    Reducing the Risk of Catheter Related Blood Stream Infections in Hemodialysis Patients
    Anil Agarwal, MBBS, MD, FACP, FASN, FISN, FNKF, FASDIN
    Professor of Medicine
    University of California San Francisco
    2:10-2:25Wolters Kluwer Sponsored Session: More information to come
    2:25-2:55Session 6: Strategies for Preventing C. difficile Infections in HospitalsLarry K. Kociolek, MD, MSCI, FSHEA, FPIDS
    Vice President, System Preparedness, Prevention, and Response; 
    Attending Physician, Division of Infectious Diseases; 
    Ann & Robert H. Lurie Children’s Hospital of Chicago
    2:55-3:00Closing Remarks: Key Takeaways

    Anil Agarwal, MBBS, MD, FACP, FASN, FISN, FNKF, FASDIN

    Professor of Medicine

    University of California San Francisco

    Anil K. Agarwal, MD, FACP, FASN, FISN, FNKF, FASDIN, is the Chief of Medicine at Veterans Affairs Central California Health Care System at Fresno, California and a Professor of Clinical Medicine at The University of California San Francisco at Fresno. Dr. Agarwal is a passionate clinician, educator, and author, and is an internationally recognized expert in hypertension, chronic kidney disease, dialysis, anemia, mineral bone disorders, and vascular access. He has conducted over 50 clinical trials, developed protocols, and published results of studies. He is a frequently sought speaker nationally and internationally. He serves and chairs many committees and boards, and also serves as editor and reviewer for several medical journals. 

    Samantha Bastow, PharmD, MBA

    Associate Director, Clinical Integration, Medical Affairs, US Region

    BD

    As the Associate Director of Clinical Integration in Medical Affairs at BD, Samantha Bastow, PharmD, MBA, is responsible for overseeing and managing both the clinical and administrative aspects of the medical division of business. This includes innovation and new product and business development, lifecycle clinical evidence generation, market shaping and development, and safety and compliance. Prior to BD, she served as the Director of Clinical Pharmacy Services at the University of Chicago Medical Center, where she led inpatient and emergency clinical pharmacy service lines, including antimicrobial stewardship, in addition to formulary management, clinical decision support, business development, research and academic responsibilities. Samantha holds a PharmD from Palm Beach Atlantic University and an MBA with a specialization in data analytics from the University of Illinois. She completed a PGY1 residency at Sarasota Memorial Hospital followed by an emergency medicine pharmacy residency at Boston Medical Center.

    Diane Flayhart, MS

    Director, Global Public Health

    BD

    As a Director in Global Public Health at BD, Diane Flayhart, MS, is responsible for leading global policy and advocacy efforts on antimicrobial resistance. She works with global stakeholders in a collaborative and programmatic approach to strengthen healthcare systems. She also leads efforts for the Antimicrobial Resistance Fighter Coalition, a global organization that seeks to increase awareness of drug-resistant infections and encourage action. Prior to joining BD, Diane managed the clinical microbiology laboratory at The Johns Hopkins Hospital.

    Larry K. Kociolek, MD, MSCI, FSHEA, FPIDS

    Vice President, System Preparedness, Prevention, and Response

    Ann & Robert H. Lurie Children’s Hospital of Chicago

    Larry K. Kociolek, MD, MSCI, FSHEA, FPIDS, is an Attending Physician in the Division of Pediatric Infectious Diseases and Vice President of System Preparedness, Prevention, and Response at Ann & Robert H. Lurie Children’s Hospital of Chicago, and he is an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. At Lurie Children’s, Dr. Kociolek leads preparedness, prevention, and response efforts for all hazards, including emerging pathogens. He serves as site PI for the HRSA-funded Pediatric Pandemic Network.

    Dr. Kociolek is the Principal Investigator of several NIH-funded translational research studies focused on the epidemiology and prevention of healthcare-associated and other high-consequence infections in children, particularly C. difficile infection and COVID-19. He serves on the Pediatric Leadership Council for the Society for Healthcare Epidemiology of America (SHEA) whose goal is to lead national advocacy, research, and education efforts for prevention of healthcare-associated infections in children. Through SHEA, he has led an international group of experts to define best practices for the prevention of C. difficile infections in adults and children in acute care hospitals.

    Payal Patel, MD, MPH, FIDSA

    System-Wide Medical Director of Antimicrobial Stewardship, Associate Professor

    Intermountain Health

    Payal Patel, MD, MPH, FIDSA, is an associate professor at Intermountain Health and the systemwide medical director of antimicrobial stewardship. She is an infectious diseases physician and is passionate about improving patient safety and antimicrobial stewardship. Dr. Patel serves on the Presidential Advisory Council on Combatting Antibiotic Resistance and has worked with developing antimicrobial stewardship programs in several countries including India, Japan, and Italy. She is the lead author on the most recent CAUTI compendium.  

    Kalvin Yu, MD, FIDSA

    Vice President of Medical Affairs, North America

    BD

    As the Vice President of Medical Affairs for North America, Kalvin Yu, MD, FIDSA, is responsible for providing medical and scientific leadership and operationally viable BD Solutions with clinicians and healthcare systems across the United States. Before BD, Dr. Yu was the Chief Integration Officer and Chief of Infectious Diseases at Southern California Kaiser Permanente, where he implemented multidisciplinary quality and patient safety programs among different hospitals and service lines. Dr. Yu trained at the UCLA School of Medicine and was a former Associate Professor of Infectious Disease and Global Public Health at NYU. Published research areas include patient outcomes, readmissions, and quality metric benchmarking. He was a member of the CDC Antibiotic Utilization workgroup, and has been an invited speaker at IDSA, SHEA, Pew Trusts, and Capitol Hill in Washington D.C. Dr. Yu was nominated and inducted as a Fellow in the Infectious Diseases Society of America in 2020.

    Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this symposium.

  • Product not yet rated Includes a Live Web Event on 11/19/2024 at 11:00 AM (PST)

    Content provided by AgileMD (No CE credits offered)

    Webinar Description: 

    Date: November 19, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    In the fight to solve sepsis, new AI powered tools have emerged to support clinicians on the front lines of patient care. Yet, not all AI is created equally, and clinical leaders need to know how to compare solutions. Further, clinical leaders need strategies for implementing AI tools successfully, because even the most advanced technology won’t save a single life if it isn’t used. This sponsored webinar will bring together experts in clinical research and quality implementation to educate attendees on the landscape of AI tools for sepsis, approaches to selecting one, and best practices for their use. The session will first provide a research-backed overview of AI tools for sepsis, including a review of published performance data. The webinar will then feature a case study from Yale New Haven Health System, highlighting lessons learned in their experience comparing and implementing several different solutions over the past few years.  

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by AgileMD for this sponsored webinar.

    Dana Edelson, MD, MS, FAHA, FHM (Moderator)

    Co-founder & Chief Medical Officer

    AgileMD

    Dana Edelson, MD, MS, FAHA, FHM, is a physician scientist and Executive Medical Director for Rescue Care and Resiliency at the University of Chicago. She is an internationally recognized expert in cardiac arrest, sepsis, and rapid response systems, with a focus on harnessing artificial intelligence and machine learning (AI/ML) to identify subtle changes in clinical stability and drive clinical workflows to prevent failure to rescue in the hospital. Dr. Edelson is a co-inventor of eCART, an FDA cleared early warning tool, and co-founder of AgileMD, a health tech start-up which delivers eCART and other clinical decision support software to hundreds of hospitals across the U.S. She has received millions of dollars in federal research funding and has over 150 peer-reviewed publications that have been widely cited. Dr. Edelson was named by Becker’s Hospital Review as one of the Women in Medtech to Know and currently serves as on the American Heart Association Resuscitation Systems of Care Advisory Group.

    Patrick G Lyons, MD, MSc

    Assistant Professor of Medicine and Informatics

    Oregon Health & Science University

    Patrick G Lyons, MD, MSc, is an intensivist and healthcare delivery scientist at Oregon Health & Science University. He has expertise in data science, human-centered design, and implementation research methods. His lab focuses on data-driven innovations in recognizing, characterizing, treating, and communicating about critical illness syndromes in special populations, such as patients with cancer. He joined the Department of Medicine and the Department of Medical Informatics and Clinical Epidemiology at Oregon Health and Science University in 2022 after serving as the inaugural Medical Director of the Healthcare Innovation Lab at Washington University School of Medicine and BJC HealthCare in St. Louis.

    Jennifer Johnson, APRN

    Program Manager, Care Signature

    Yale New Haven Health

    Jennifer Johnson, APRN, is a critical care nurse practitioner at Yale New Haven Health Care, where she has gained extensive experience leading quality improvement efforts across a large health system. She’s developed expertise leading diverse groups to obtain consensus and change practice to be more evidence-based and data-oriented.  Her work has led to improvements in outcomes, including reduction in mortality, improvements in length of stay, and cost savings. She co-leads Yale New Haven Health’s eCART initiative and works clinically in the Tele ICU.

    Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.

  • Includes a Live Web Event on 10/30/2024 at 11:00 AM (PDT)

    Learn how the new Z51.A code is crucial for healthcare providers to document follow-up care for sepsis survivors who may be at risk for recurrent infections or dealing with the long-term effects of sepsis, such as post-sepsis syndrome (PSS).

    Description: 

    Date: October 30, 2024

    Time: 2:00 - 3:00 pm ET

    Sepsis affects over 1.7 million Americans each year and the Centers for Disease Control (CDC) reports that 75% of sepsis deaths in the U.S. occur in the Medicare population, with a death rate exceeding 300 per 100,000 people. Sepsis survivors face a higher risk of recurrence and readmission, particularly if they’ve been in intensive care. In July 2024, CMS released the FY 2025 ICD-10-CM code update, effective from October 1, 2024, to September 30, 2025. This update includes a new code, Z51.A ‘Encounter for Sepsis Aftercare,’ which allows providers to document sepsis aftercare and warn patients about potential risks, such as new or recurring infections, and offer rehabilitation for impairments.

    In this informative presentation, Dr. Kathy Bowles will discuss how the new Z51.A code is crucial for healthcare providers to document follow-up care for sepsis survivors who may be at risk for recurrent infections or dealing with the long-term effects of sepsis, such as post-sepsis syndrome (PSS). It ensures that ongoing care, like monitoring for new infections or rehabilitation for impairments, is properly recorded.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Describe the use case for ICD-10 code Z51.A 'Encounter for Sepsis Aftercare;’
    • Identify the barriers to information transfer during transitions in care for sepsis survivors and suggest strategies for improvement;
    • Identify appropriate applications of ICD-10 code Z51.A in various healthcare settings.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Kathryn Bowles PhD, RN, FAAN, FACMI

    Professor of Nursing, University of Pennsylvania School of Nursing

    Director of the Center for Home Care Policy & Research, VNS Health

    Kathryn Bowles PhD, RN, FAAN, FACMI, is a Professor of Nursing and the van Ameringen Chair in Nursing Excellence at the University of Pennsylvania School of Nursing. She is the Vice President and Director of the Center for Home Care Policy & Research at VNS Health. Her program of research in clinical decision support and implementation science for discharge planning, transitions in care, and home care with vulnerable older adults has been continuously funded for 25 years. She has served on many national committees and workgroups to advance the care of older Americans such as the National Quality Forum, the Care Coordination Steering Committee ,and the Heath Information Technology Standards Panel (HITSP) Care Coordination Committee. She was an invited expert consultant on the Centers for Medicare Services (CMS) Technical Expert Panel on the Post-Acute Care Assessment instrument (CARE tool) and two other Expert Panels to develop measures for transitions in care and continuity of care.

    Dr. Bowles co-founded RightCare Solutions, a software company based on her team's research on decision support for post-acute care referrals. She was appointed to the National Institute of Nursing Research (NINR) Advisory Council and delivered the 2016 NINR Director's Lecture. She was invited by the National Academy of Medicine and the Office of the National Coordinator for Health Information Technology to discuss optimizing strategies for clinical decision support.  She is a fellow in the American Academy of Nursing and the American College of Medical Informatics, a member of the American Nurses Association (ANA), and Sigma Theta Tau International Honor Society where she was inducted into the International Nursing Research Hall of Fame.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.2 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

    Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.

  • Content provided by Spectral Medical (No CE credits offered)

    Webinar Description: 

    What part does endotoxin play in the etiology of sepsis and septic shock? This sponsored webinar will describe the human response to elevated levels of endotoxin, both as an adaptive immune response and also as a trigger of sepsis. The ability to measure endotoxin activity in the bloodstream allows clinicians to uncloak its true prevalence and closely examine when endotoxin plays a role in sepsis. Can targeting endotoxin removal be a successful treatment modality for sepsis? Tune in to this webinar to learn more.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by Spectral Medical for this sponsored webinar.

    image


    Debra Foster, BSc

    Clinical Consultant

    Spectral Medical

    Debra M. Foster, BSc, spent 11 years as an RN in the adult critical care area. Thereafter, Debra joined the critical care clinical research team at Toronto General Hospital. She was project lead for a multi-national, multi-center clinical trial - the MEDIC study. The data was used for a successful 510(k) de novo submission to the FDA for the Endotoxin Activity Assay (EAA). It was the first IVD for sepsis. Debra went on to follow the device to its commercial partner, Spectral Medical, Inc. She became VP of Clinical Development in 2011.  Debra led many clinical research projects, including the MEDIC, EUPHRATES, and TIGRIS clinical trials, aimed at endotoxin in critical illness. Currently, Debra is a clinical consultant for Spectral Medical. She has lectured to medical professionals on the topics of sepsis, endotoxin, and clinical trials for sepsis and has been a co-author of more than 50 articles in peer-reviewed journals.  

    Mark A. Tidswell, MD

    Professor of Medicine

    UMASS Chan Medical School – Baystate

    Mark A. Tidswell, MD, is a Professor of Medicine at UMASS Chan Medical School – Baystate. Trained asa pulmonary and critical care physician, his clinical practice is adult critical care and neurocritical care at Baystate Medical Center in Springfield, MA. He began work in multi-center clinical trials 25 years ago. He was an active contributor to the NHLBI research networks ARDSnet and PETAL from 2000 – 2024, which studied thousands of patients with ARDS, sepsis, and COVID-19. He serves as site PI for pharmaceutical trials in the area of sepsis and ARDS and has 20 years of experience using the Endotoxin Activity Assay to identify endotoxemia in patients in clinical trials. Dr. Tidswell was an investigator in the EUPHRATES trial and is part of the scientific steering committee for the TIGRIS study. He is a co-author and contributor to more than 90 publications.

    Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.

  • Annual, virtual conference covering sepsis-related topics and offering RN CE Contact Hours

    Description

    *Over 350,000 U.S. adults killed each year.*

    *The leading cause of death in U.S. hospitals.*

    *Over 49 million people worldwide affected each year.*

    This is sepsis.

    Join us to learn more about how you can help better identify, diagnose, and treat this deadly condition in your practice. Mortality increases 4-9% for every hour that treatment is delayed. YOU can help save lives and limbs by staying up-to-date on current recommendations and guidelines around sepsis by joining us at the 5th Annual Sepsis Alliance Summit.

    For the first time, Sepsis Alliance Summit is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.

    Are you ready to learn with us? Register today for this free, virtual conference. You’ll earn RN CE credits and improve your practice, benefiting sepsis patients.

    FREE Nursing CE Credits Offered! 

    Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing for 15.0 contact hours, Provider Number CEP17068.

    Conference Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:

    image


    Agenda

    September 25, 2024

    Time (ET)Session TitlePresenter
    10:00-10:15Opening Remarks & The 2024 Erin Kay Flatley Spirit Award WinnersCarl Flatley, DDS, MSD
    Founder, Sepsis Alliance

    Jackie Duda
    Health and Travel Journalist
    Sepsis and Disability Advocate

    Julia Fraser
    Sepsis Survivor, Mrs. Texas
    10:20-10:30Day 1 Keynote: Advocacy and Awareness: Our Family's Journey with Sepsis and the Power of ‘Using Your Voice’Jake Tapper
    Anchor and Chief Washington Correspondent, CNN

    Alice Tapper
    Student & Patient Advocate

    Jennifer Tapper
    Sepsis Alliance – Board of Directors
    10:35-11:00Recognizing the Overlooked: Identifying Features of Delayed Sepsis Diagnoses (CE Session)Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE
    Director, Safe Medical Care Research Canadian Medical Protective Association

    Eileen Bridges, MD, CCFP, MSc, Dip Sport Med.
    Senior Physician Advisor, Safe Medical Care Learning Canadian Medical Protective Association
    11:00-11:30A Sepsis Documentation Journey: Memorial Hospital of Union County (Ohio) (CE Session)Amy Stephens, MBA, RN, CPHQ, CHC
    Assistant Vice President of Quality and Compliance, Memorial Hospital

    Robin Regula, RN
    Clinical Quality Specialist
    Memorial Hospital
    11:30-12:00Track 1: Recce Pharmaceuticals Sponsored Session: New Frontiers in Sepsis and Urosepsis Treatment: Synthetic Anti-Infectives to Combat Superbugs

    Track 2: Abionic Sponsored Session: Rapid Sepsis Screening - Can Pancreatic Stone Protein (PSP) Enhance ED Triage?
    Track 1: James Graham
    Managing Director & Chief Executive Officer, Recce Pharmaceuticals

    Track 2: Andrew Shorr, MD

    Section Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center (MWHC)

    Evangelos J. Giamarellos-Bourboulis, MD, PhD
    Professor of Internal Medicine and Infectious Diseases, Medical School of the National and Kapodistrian University of Athens

    Patrick Pestalozzi, MBA Chief Executive Officer, Abionic
    12:00-12:15Break
    12:15-12:45Racial and Ethnic Disparities in Sepsis (CE Session)Christopher F. Chesley, MD, MSCE
    Assistant Professor of Medicine Perelman School of Medicine at the University of Pennsylvania
    12:50-1:20Post-Intensive Care Syndrome in Survivors of Sepsis (CE Session)Tracye Proffitt, PhD, RN, CNE
    Assistant Professor
    Virginia Commonwealth University School of Nursing 
    1:25-1:55bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient JourneyDaniel Feinstein, MD, MS, FACP, ACRP-PI
    Director of Pulmonary Critical Care Medicine, Novant Healthcare
    1:55-2:10Break

    2:10-2:40Neonatal Sepsis: A Global Challenge (CE Session)Pascal Lavoie, MDCM, PhD
    Professor of Pediatrics
    University of British Columbia
    2:45-3:30Sepsis: Threat to Cardiovascular Health (CE Session)Mitchell S. V. Elkind, MD, MS
    FAHA Chief Clinical Science Officer American Heart Association
    3:35-3:50
    Track 1: Roche Sponsored Session: Immunotherapy of Sepsis Guided by Biomarkers

    Track 2: Flosonics Medical Sponsored Session: Cracking SEP-1: Your Guide to Acing Fluid Administration Requirements
    Track 1: Richard S. Hotchkiss, MD
    Professor of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine

    Track 2: Jaclyn Bond, MSN-LM, MBA-HM, RN
    Director of Nursing, Riverside University Health System
    3:55-4:10Track 1: InflaRx Sponsored Session: For Some Patients, COVID-19 Remains a Serious Threat

    Track 2: SeaStar Medical Sponsored Session: Pediatric Sepsis, The Unique Fallout of a Global Killer 
    Track 1: Bruce P. Burnett, PhD
    VP, Head of Medical Affairs, InflaRx

    Track 2: Rajit K. Basu, MD, MS, FCCM
    Division Chief of Critical Care Medicine
    Ann & Robert Lurie Children’s Hospital of Chicago
    4:15-4:45Advancing Health Equity for Sepsis Patients with Limited English Proficiency: Reducing Length of Stay and Readmissions (CE Session)Moojan Rezvan, MBA
    Supervisor, Interpreter Services & Diversity Services, Providence Mission Hospital

    Emily Cusick, BSN, RN, CCRN
    Sepsis Clinical Coordinator
    Providence Mission Hospital
    4:50-5:00Day 1 Closing RemarksHannah Sass
    Sepsis Alliance

    September 26, 2024

    Time (ET)Session TitlePresenter
    10:00-10:15Opening Remarks & Patient ExperienceHannah Sass
    Sepsis Alliance
    10:20-10:50Day 2 Keynote: The Changing Climate of Infectious Diseases and Sepsis (CE Session)Reducing Harm Related to Sepsis and InfectionsMatthew C. Phillips, MD, PhD
    Clinical and Research Fellow Massachussetts General Hospital
    10:55-11:25Reducing Harm Related to Sepsis and Infections (CE Session)David W. Bates, MD, MSc Co-Director Artificial Intelligence and Bioinformatics in the Learning Healthcare System
    Mass General Brigham
    11:30-12:00Track 1: Baxter Sponsored Session: Changing Landscape for Sepsis: Value-based Purchasing and The New CDC Hospital Sepsis Program Core Elements

    Track 2: Wolters Kluwer Sponsored Session: The Human Impact of Sepsis Identification and Management
    Track 1: Pat Posa, RN, BSN, MSA, CCRN, FAAN
    Quality and Safety Program Manager
    Hospital Medicine Safety (HMS) Coordinating Center, University of Michigan

    Track 2: Elizabeth Tomaszewski, DNP, RN, CRNP, CNE, CCRN, ACNP-BC, ACNPC
    Clinical Content Manager, Lippincott Solutions, Lippincott Certification Review
    12:00 - 12:15Break
    12:15-12:45
    Hospital Care at Home in the Continuum of Care for Sepsis (CE Session)
    Grace Jenq, MD
    Clinical Professor, Geriatric and Palliative Medicine; Associate Chief Clinical Officer, Post-Acute Care Services University of Michigan Medicine
    12:50-1:20Sepsis Patient Education as Quality Improvement (CE Session)Bethany Koschel, DO
    Internal Medicine Physician
    Providence St. Vincent Internal Medicine
    1:25-1:40T2 Biosystems Sponsored Session: Advancing Sepsis Detection in ICUs: Assessing the Benefits and Integration of T2Candida in Clinical Practice
    Cristian Merchan, Pharm.D., BCCCP
    Assistant Director of Clinical Pharmacy Services - Critical Care, Emergency and Perioperative Services
    NYU Langone Health
    1:45-2:00Track 1: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story

    Track 2: Inflammatix Sponsored Session: Advances in Emergency Medicine Diagnostic Testing: Reducing Clinical Ambiguity with Patients Suspected of Acute Infections or Sepsis
    Track 1: Hollis (Bud) O'Neal, MD
    Associate Professor of Medicine Louisiana State University Health Sciences Center

    Mark Laperouse, MD
    Medical Director Emergency Services Our Lady of the Lake Regional Medical Center

    Track 2: 
    Tim Sweeney, MD, PhD
    Co-Founder and CEO
    Inflammatix
    2:00-2:15Break
    2:15-2:45Sepsis in the Cardiac Intensive Care Unit: Early Goal-Directed Mechanical Circulatory Support?
    (CE Session)
    Jonathan Ludmir, MD
    Assistant Professor of Medicine Massachusetts General Hospital, Harvard Medical School
    2:50-3:25Earlier Recognition and Response to Critical Illness Outside the ICU (CE Session)Frank Sebat, MS, MS, FCCM
    Director, Kritikus Foundation
    3:30-3:55Boston Scientific Sponsored Session: Intrarenal Pressure During Flexible Ureteroscopy
    Manoj Monga, MD, FACS, FRCS
    Professor and Chair of Department of Urology, University of California San Diego

    Naeem Bhojani, MD
    Professor of Surgery
    University of Montreal

    Ben H. Chew, MD, MSc, FRCSC
    Associate Professor of Urology
    University of British Columbia
    4:00-4:15Use of Virtual Reality for Sepsis Recognition and Management Training (CE Session)Matthew Zackoff, MD, MEd
    Assistant Professor, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center
    4:20-4:30Closing Remarks

    September 27, 2024

    For the first time, Sepsis Alliance is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.

    Time (ET)Session TitlePresenter
    10:00-10:10
    Opening Remarks and Land Acknowledgement
    David Carlbom, MD
    Associate Professor of Medicine, Pulmonary Critical Care and Sleep Medicine University of Washington School of Medicine Medical Director, Respiratory Care Department Attending Physician, Medical and Trauma-Surgical Intensive Care Units Harborview Medical Center

    Katy Grainger
    Sepsis Survivor and Advocate
    10:10-10:55Session 1: Implementation of Pediatric Sepsis Phoenix Criteria Across the Globe: Building Equity?

    10:10-10:15  Introductions

    10:15-10:30  Development of the Phoenix Criteria for Sepsis and Septic Shock in Children

    10:30-10:45 
     The Phoenix Pediatric Sepsis Definitions - Applying Them in South Africa

    10:45-10:55
      Panel Discussion
    Moderator: Scott P. Sherry, MS, PA-C, FCCM
    Sepsis Program Manager, Oregon Health and Science University  Doernbecher Children’s Hospital

    Nelson Sanchez-Pinto, MD, MBI, FAMIA
    Northwestern University - Feinberg School of Medicine

    Andrew Argent, MBBCh, MMed, MD, FRCPCH (UK)
    11:00-11:55Session 2: Challenges & Opportunities for Improving Maternal Sepsis Care

    11:00-11:05  Introductions

    11:05-11:18
     Midwives’ role in preventing maternal and neonatal sepsis in Low- and Middle-Income Countries

    11:18-11:31 
     Addressing Maternal Sepsis: A Large-Scale Quality Improvement Approach

    11:31-11:44   
    Practical approaches to addressing maternal sepsis in Low-to-Middle Income Countries

    11:44-11:55
      Panel Discussion
    Moderator: Scott P. Sherry, MS, PA-C, FCCM
    Sepsis Program Manager, Oregon Health and Science University  Doernbecher Children’s Hospital

    Cathryn Ellis. BFA, MSc. PhD, RM (non-practicing)

    Associate Professor Emeritus
    University of British Columbia

    Elliott K. Main, MD
    Professor of Obstetrics and Gynecology Stanford University School of Medicine

    María Fernanda Escobar Vidarte, MD Chief of the Global Health Equity Unit Fundacion Valle del Lili
    12:00-12:30Break
    12:30-1:30Session 3: Bedside Education - Teaching Providers How to Apply Best Practices

    12:30-12:35  Introductions

    12:35-12:53
      The Hard Part - Turning Guidelines Into Practice

    12:53-1:11 
      Transformational Leadership: People-Centered Framework to Address Antimicrobial Resistance, the Silent Tsunami!

    1:11-1:25
        Panel Discussion
    Moderator: Rick Janik, BSN, RN, CEN, CFRN
    Flight Nurse, Airlift Northwest

    Laura Evans, MD, MSc
    Professor and Medical Director
    Critical Care, University of Washington

    Halima Salisu-Kabara, FWACN, MPA, RN-RM, CCRN
    Vice-Executive Director African Sepsis Alliance (ASA)
    1:30-2:25Session 4: Bench to Bedside: Updates in Sepsis Science

    1:30-1:35  Introductions

    1:35-2:20 
    Sepsis Research Update: Considerations for All Care Settings

    2:20-2:25
      Q&A
    Moderator: Mary Jo Kelly DNP, ARNP-CNS, CCNS, CCRN

    Elizabeth Bridges PhD, RN, CCNS, FCCM, FAAN
    University of Washington Medical Center
    2:30-3:25Session 5: Sepsis Survivorship

    2:30-2:35  Introductions

    2:35-2:43
      Journey to Sepsis Survivorship: Patient Perspective

    2:43-2:56 
     Sepsis Aftercare: Improving the Lives of Sepsis Survivors

    2:56-3:09  
    Sepsis Transition and Recover (STAR), Nurse Navigators Delivering Best Practice Post-Discharge Care

    3:09-3:25
      Panel Discussion
    Moderator: Sybil Hoiss, RN, MN
    Lead, Clinical Initiatives & Innovation Critical Care BC, Provincial Health Services Authority

    Hailey Bain
    Sepsis Survivor and Patient Partner Sepsis Canada

    Mark E. Mikkelsen, MD, MSCE, FCCM
    Associate Chief Medical Officer, Critical Care University of Colorado Hospital

    Stephanie Taylor, MD, MS
    Division Chief of Hospital Medicine University of Michigan
    3:30-4:00Closing Remarks: Pulling It All TogetherFatima Sheikh, MSc
    Communications Assistant
    Sepsis Canada

    Katy Grainger
    Sepsis Survivor and Advocate
  • Content provided by bioMérieux (No CE credits offered)

    Webinar Description: 

     Join us for a sponsored webinar on “The Impact of Prioritizing Sepsis Management and Diagnostic Stewardship in the C-Suite,” where we will delve into the critical importance of executive leadership in enhancing sepsis care. This session will explore the seven core elements of a robust sepsis program, the implementation of the 3- and 6-hour sepsis bundles, and the pivotal role of diagnostics in early detection and treatment. Attendees will gain a comprehensive understanding of current best practices and strategies, as well as a forward-looking perspective on the future of sepsis care, ensuring improved patient outcomes and operational efficiency.

    No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

    Webinar Sponsor: 

    Sepsis Alliance gratefully acknowledges the support provided by bioMérieux for this sponsored webinar.

    image


    Minkey Wungwattana, PharmD, BCIDP

    Field Medical Director, U.S. Medical Affairs

    bioMérieux

    Minkey Wungwattana, PharmD, BCIDP, is a Field Medical Director with bioMérieux. He received his Doctor of Pharmacy degree from Purdue University in 2011 and completed his post-graduate residency training in infectious diseases at Indiana University Health in Indianapolis, IN. After the completion of residency training, he became the Antimicrobial Stewardship Program (ASP) director at Maine Medical Center  in Portland, ME. He was successful at implementing rapid diagnostic platforms during his 10 years of clinical practice at Maine Health. His areas of interest include optimizing the outcomes of infectious diseases patients with limited resources, diagnostic stewardship, and myth busting outdated infectious disease dogmas.

  • Content presented by Cytovale (No CE Credits)

    Description: 

    Join us for a sponsored webinar featuring Cytovale’s IntelliSep sepsis test where we will talk about how this novel technology is changing the way patients are triaged in the ED, leading to faster, more accurate detection of sepsis and appropriate care. You will learn insights into what makes sepsis so challenging to diagnose and how IntelliSep can help. You will also meet leaders from Our Lady of the Lake Regional Medical Center, including Dr. Hollis O’Neal, who will share the impact that IntelliSep has had on their patients, day-to-day processes, and the organization broadly. For more information, visit our website cytovale.com.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Hollis (Bud) O'Neal, MD

    Associate Professor of Medicine

    Louisiana State University Health Sciences Center

    Bud O’Neal, MD, is an Associate Professor of Clinical Medicine at LSU Health Sciences Center (LSUHSC) and the Medical Director of Research for Our Lady of the Lake Regional Medical Center in Baton Rouge. Dr. O’Neal graduated from Vanderbilt University with a Bachelor of Science in Molecular Biology and Computer Science, and subsequently completed medical school at the Louisiana State University Health Sciences Center in New Orleans. He completed his internal medicine residency at the Louisiana State University Health Sciences Center in Baton Rouge. He then completed Pulmonary and Critical Care Medicine training at Vanderbilt University, where he also earned a Master of Science in Clinical Investigation. Dr. O’Neal is a member of the American Thoracic Society, American Society of Microbiology, and the American Academy for the Advancement of Science. He is an active investigator in clinical trials, including industry-sponsored, NIH-funded, and investigator-initiated studies. His research interests include sepsis diagnosis and treatment.

    Summit 2024 Session: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story

    Session Day/Time: Thursday, September 26, 2024, 1:45 PM - 2:00 PM EST

    Access Session

    Rob Scoggins, MD, PhD

    Medical Director of Critical Care, Respiratory Therapy and Pulmonary Rehab

    Kootenai Health

    Nicole Voelker, RN

    Our Lady of the Lake Regional Medical Center

  • This live, virtual event, will cover critical topics related to sepsis in immunocompromised patients, including a special focus on patients with cancer and patients with HIV.

    Description: 

    Date: August 1, 2024

    Time: 12:00 - 4:00 pm ET / 9:00 am - 1:00 pm PT

    While sepsis is an equal-opportunity killer impacting the sick, the well, and people of all ages, some groups are more likely to be affected. Those with a weakened immune system[1] are one of the groups more likely to be affected by sepsis. Individuals with any type of primary immune deficiency, human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), cancer, organ transplants, or those on certain types of medications, like corticosteroids, are all considered immunocompromised.[2]

    Sepsis is a leading cause of death, killing an estimated 350,000 adults each year in the U.S..[3] Immunocompromised patients are even more likely to die from sepsis. For instance, sepsis mortality amongst cancer patients is 43-55% higher than in patients who do not have cancer.[4] Immunocompromised patients may also present differently than patients who are not immunocompromised, due to a variable inflammatory response, leading to potential delays in diagnosis and treatment.[5] This creates additional complications, as the risk of mortality from sepsis increases by 4-9% for every hour treatment is delayed.[6]

    It is imperative that healthcare professionals understand the unique risks that immunocompromised patients have regarding sepsis to efficiently and accurately assess and diagnose sepsis in immunocompromised patients.

    To address this issue, Sepsis Alliance is hosting the 2024 Sepsis Alliance Symposium: Sepsis in Immunocompromised Patients. This live, virtual event, will cover critical topics related to sepsis in immunocompromised patients, including a special focus on patients with cancer and patients with HIV.  Attendees will have access to the most up-to-date clinical knowledge and treatment recommendations for these populations. The key outcome of this half-day event is to establish the burden of sepsis in immunocompromised patients and improve clinical outcomes for immunocompromised patients affected by sepsis.

    Covered topics will include:

    1. Infection and sepsis burden and risks in the immunocompromised host;
    2. Sepsis recognition and care considerations in the immunocompromised patient;
    3. Sepsis and acute respiratory failure in patients with cancer;
    4. The effect of HIV infection on the host response to bacterial sepsis;
    5. Outcomes of patients with or without HIV infection.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Identify the unique risks and burden of sepsis on immunocompromised patients;
    • Summarize the steps to recognizing sepsis in immunocompromised patients;
    • Restate the signs of acute respiratory failure in patients with cancer and sepsis;
    • Summarize the relationship between HIV and the host response to bacterial sepsis.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Supporters:

    Sepsis Alliance gratefully acknowledges the support provided by Gilead and Baxter for this symposium.

    image

     

    image

    Andre Kalil, MD, MPH, FACP, FIDSA, FCCM

    Professor of Medicine, Director of Transplant Infectious Diseases Program

    University of Nebraska Medical Center

    Andre Kalil, MD, MPH, FACP, FIDSA, FCCM, is a practicing physician, professor of medicine, and researcher at the University of Nebraska Medical Center in Omaha, Nebraska. He is the Director of the Transplant Infectious Diseases Program at the University of Nebraska and has been the principal investigator for multiple randomized controlled trials in sepsis, pneumonia, and COVID-19. 

    Dr. Kalil has received numerous honors and awards, including the 2021 Scientist Laureate Award. He has been a peer-reviewer and editor for major medical journals and has published over three hundred PubMed indexed scientific articles. 

    Jared Greenberg, MD, MSc

    Associate Professor, Department of Internal Medicine; Assistant Director, Medical Intensive Care Unit

    Rush University Medical Center

    Jared Greenberg MD, MSc is an Associate Professor in the Division of Pulmonary and Critical Care Medicine at Rush University Medical Center in Chicago, IL. He spends most of his clinical time providing care to patients in the medical Intensive Care Unit (ICU). He has conducted multiple studies dealing with sepsis in immunocompromised hosts. Dr. Greenberg’s current research interests involve exploring novel ways to communicate with families of critically ill patients in ways that help them make informed decisions for their loved ones. He is also interested in improving the ability of clinicians to identify families who are experiencing emotional distress during and after an ICU stay and to provide support that is individualized to their needs.    

    May Mei-Sheng Riley, MSN, MPH, RN, ACNP, CCRN, CIC, FAPIC

    Infection Control Consultant

    Stanford Health Care

    May Riley, MSN, MPH, RN, ACNP, CCRN, CIC, FAPIC is an Infection Control Consultant at Stanford Health Care. May has been practicing in infection control and hospital epidemiology since 2005. She has extensive nursing experience, including medical/surgical, neurosurgery, trauma, liver transplant, and critical care nursing. May holds two master's degrees, an MSN in acute care from the UCLA School of Nursing and an MPH in epidemiology from the UCLA School of Public Health. Currently, she is a doctoral student at San Jose State University. 

    May's influence on infection prevention and infectious disease control is profound. Her contributions extend beyond her role as a subject matter expert on the ANA/CDC Work Group for Engaging Nurses in Antibiotic Stewardship, where she was an editorial contributor to the Prevention Strategist in 2016. May's impact is also evident in her numerous publications, including articles, books, book chapters, online education modules, and presentations. Her dedication to the infection control community is commendable. 

    May is also a Consulting Editor for the Journal of Critical Care Nursing Clinics of North America, published by Elsevier, and a Peer Reviewer for the Journal of AORN (Association of Perioperative Registered Nurses). 

    Lisa Torres, MD, MS

    Assistant Professor, Division of Pulmonary and Critical Care Medicine

    New York Presbyterian – Weill Cornell Medical Center

    Lisa Torres, MD, MS, is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine at New York Presbyterian – Weill Cornell Medical Center. She earned her MD from the Royal College of Surgeons in Ireland and an MS in Clinical and Translational Investigation from Weill Cornell Graduate School of Medical Sciences. After her internship in the Irish Health Service Executive, Dr. Torres completed residency training in Internal Medicine at the University of Texas Health Science Center at Houston, followed by a Fellowship in Pulmonary and Critical Care Medicine at New York Presbyterian - Weill Cornell Medical Center.  

    Dr. Torres is a clinician and translational investigator studying sepsis-induced immune suppression in critically ill patients. These “immune paralyzed” patients are at highest risk for opportunistic infections and mortality. Her work is focused on understanding alterations in immune cell metabolism and impaired cell signaling associated with immune paralysis. She is supported by an NIH K23 award from the National Institute of General Medical Sciences, the Houston Methodist – Weill Cornell Medicine Pilot Award, as well as the NIH Loan Repayment Program via the National Heart, Lung, and Blood Institute. Dr. Torres attends on both the Medical Intensive Care Unit and Pulmonary Consult Services at the New York-Presbyterian Weill Cornell and Lower Manhattan Hospital campuses. 

    Greg Martin, MD, MSc

    Director, Predictive Health Institute and Center for Health Discovery and Wellbeing; Professor of Medicine; Executive Associate Division Director Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine

    Emory University School of Medicine

    Greg Martin, MD, MSc, is Professor of Medicine in the Emory University School of Medicine and Associate Division Director for Critical Care at Emory University in the Division of Pulmonary, Allergy, Critical Care and Sleep MedicineDr. Martin conducts clinical and translational research in critically ill patients, with his primary interests being in sepsis, organ dysfunction syndromes, and acute respiratory distress syndromeHe is internationally recognized for his pioneering work in the epidemiology of critical illness and his innovative studies focused on improving patient-centered outcomes. He is the co-author of over 100 scientific articles, reviews, book chapters, editorials, and scientific abstracts, and has given lectures at institutional, national and international conferences.  Dr. Martin completed his undergraduate studies at Duke University; medical school, residency and subspecialty fellowship training were completed at Vanderbilt University, and a post-graduate Master of Science in Clinical Research (MSCR) degree at Emory University. 

    Jacqueline Squire, MD

    Assistant Professor of Medicine, Consultant in the Division of Allergy, Department of Internal Medicine

    Mayo Clinic Florida

    Jacqueline Squire, MD, is an Assistant Professor of Medicine and consultant in the Department of Allergy and Immunology at Mayo Clinic in Jacksonville, Florida Dr. Squire attended medical school at the University of Miami Miller School of Medicine, completed a pediatric residency at Duke University Hospital, and a fellowship in Allergy/Immunology at USF/Johns Hopkins All Childrens Hospital. Her primary clinical and research interest is in inborn errors of immunity and secondary immunodeficiency. She has authored multiple peer-reviewed articles published in the leading allergy and immunology journals and given regional and national presentations on immunodeficiency.  

    Agenda


    Time (ET)Session TitlePresenter
    12:00-12:10Opening Remarks & Patient StoryGreg Hourigan
    Sepsis Survivor
    12:10-12:40Sepsis Survival and Outcomes in Immunocompromised and Transplant PatientsAndre Kalil, MD, MPH, FACP, FIDSA, FCCM
    Professor of Medicine, Director of Transplant Infectious Diseases Program at
    University of Nebraska Medical Center
    12:40-1:10Sepsis in Immunosuppressed Patients with CancerJared Greenberg, MD, MSc
    Associate Professor, Department of Internal Medicine; Assistant Director, Medical Intensive Care Unit at Rush University Medical Center

    1:10-1:40Invasive Fungal Infections Among Immunocompromised Patients: Focusing on Infection Control and Risk Mitigation May Mei-Sheng Riley, MSN, MPH, RN, ACNP, CCRN, CIC, FAPIC
    Infection Control Consultant at Stanford Health Care
    1:40-2:05BREAK
    2:05-2:20Sepsis and Children
    2:20-2:50Sepsis-Induced Immune ParalysisLisa Torres, MD, MS
    Assistant Professor, Division of Pulmonary and Critical Care Medicine at New York Presbyterian - Weill Cornell Medical Center
    2:50-3:20How HIV Infection Alters Sepsis
    Greg Martin, MD, MSc
    Director, Predictive Health Institute and Center for Health Discovery and Wellbeing; Professor of Medicine; Executive Associate Division Director Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine at Emory University School of Medicine
    3:20-3:50Infection, Sepsis Risks, and Current Guidelines in Patients with AspleniaJacqueline Squire, MD
    Assistant Professor of Medicine, Consultant in the Division of Allergy, Department of Internal Medicine at Mayo Clinic Florida
    3:50-4:00Closing Remarks and Key Takeaways

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Attendees will learn how one organization was able to leverage organizational initiatives to drive meaningful change.

    Description: 

    Date: July 18, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    In anticipation of Sepsis Awareness Month in September, this presentation will showcase innovative strategies for promoting sepsis awareness, quality improvement, and patient safety within healthcare teams during Sepsis Awareness Month and year-round. Attendees will learn how one organization was able to leverage organizational initiatives to drive meaningful change. Through unique and engaging awareness and advocacy efforts that promoted collaboration with key stakeholders and leaned into the power of community partnerships to coordinate inter-disciplinary efforts, this team built a successful advocacy campaign.

    Utilizing available resources to plan and execute impactful sepsis awareness events that promote continuous improvement and patient safety will also be shared. Whether you’re a healthcare professional, administrator, or advocate, this presentation will equip you with the knowledge and tools needed to make a difference during Sepsis Awareness Month and in the fight against sepsis year-round. Get started now with Sepsis Alliance's Sepsis Awareness Month resources at SepsisAwarenessMonth.org.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • List organizational initiatives that can be used to promote sepsis awareness, quality improvement, and patient safety in a healthcare team;
    • Identify ways to collaborate with key stakeholders in healthcare advocacy events;
    • Describe how to use available resources to plan a successful sepsis advocacy and awareness event that promotes continuous improvement.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors. 

          

    image
    image

    Michelle Evans, MSN, RN, APRN, NP-C

    APP Sepsis Program Coordinator

    Summa Health

    Michelle Evans, MSN, RN, APRN, NP-C, obtained her ADN in 1999 and BSN in 2007, both from Walsh University. She earned her Masters as an Advanced Practice Nurse in 2010 from Malone University and is board-certified through the ANCC as a Family Nurse Practitioner. Her clinical background is in Critical Care/Rapid Response and Hospitalist Medicine. Michelle discovered her passion for sepsis care while serving as the Intensivist Program Coordinator for Aultman Hospital from 2002-2009. She has been the Sepsis Program Coordinator for Summa Health System in Akron since January 2021. Michelle resides in Canton, Ohio, with her husband Dave, and has three adult sons. 

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

  • Learn how one organization created a unique QI initiative to promote peer-to-peer learning by collaboratively learning from defects, discovering barriers, and creating action plans.

    Description: 

    Date: June 14, 2024

    Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

    Continuous quality improvement (QI) is at the heart of good patient care and working toward improved patient outcomes for those affected by infections and sepsis. At University Hospitals, a unique QI initiative was created to promote peer-to-peer learning by collaboratively learning from defects, discovering barriers, and creating action plans. Details on how the QI project was launched alongside the real-world examples of peer-to-peer sepsis quality improvement initiatives in action will be shared by the team at University Hospitals. Attendees will gain insight into the essential components of such initiatives, including setting objectives and key results, and discover how they drive measurable improvements in patient care.

    Learning Objectives: 

    At the end of the activity, the learner should be able to:

    • Articulate the components of a peer-to-peer quality improvement (QI) initiative;
    • Identify objectives and key results as part of a QI project;
    • Describe the process of learning from defects.

    Target Audience: 

    Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

    Webinar Supporters:

    Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors. 

          

    image
    image

    Peter Pronovost, MD, PhD, FCCM

    Chief Quality & Clinical Transformation Officer; Veale Distinguished Chair in Leadership and Clinical Transformation

    University Hospitals

    Peter Pronovost, MD, PhD, FCCM, is a world-renowned patient safety champion, physician executive, critical care physician, and prolific researcher with more than 1,000 peer-reviewed publications. He is also an innovator who has founded several technology companies and a thought leader informing U.S. and global health policy.

    Dr. Pronovost’s transformative work leveraging checklists to reduce central line-associated bloodstream infections has saved thousands of lives and earned him national acclaim. This life-saving intervention has been implemented across the U.S., and as a result, central line-associated infections that used to kill as many people as breast or prostate cancer have been reduced by 80 percent. In recognition of this innovation, his highest-profile accolades include being named one of the 100 most influential people in the world by Time Magazine and receiving a coveted MacArthur Foundation “genius grant.”

    While serving as Chief Clinical Transformation Officer at University Hospitals Health System in Cleveland and as a Professor in the Schools of Medicine, Nursing, and Management at Case Western Reserve University, Dr. Pronovost developed a checklist to make visible defects in value and deployed a management and accountability system to eliminate those defects. This system reduced the annual cost of care for Medicare patients by 30% over three years while improving quality. In 2022, Dr. Pronovost lead the efforts that culminated in University Hospitals winning the American Hospital Association’s Quest for Quality award, the industry’s most prestigious honor recognizing its member organizations for their commitment to quality. He was named the Veale Distinguished Chair in Leadership and Clinical Transformation in 2023.

    Along with the deputy secretary of Health and Human Services (HHS), Dr. Pronovost co-chaired the Healthcare Quality Summit, an initiative created in response to President Trump’s White House Executive Order to modernize and improve quality measures for HHS, Veterans Affairs and Department of Defense. Dr. Pronovost also serves as a member of the Presidents Council for Science and Technology Patient Safety Working Group that is producing recommendations for improving safety to President Biden.

    Dr. Pronovost previously served as Johns Hopkins Medicine Senior Vice President for Patient Safety and Quality and was the founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. He also served as the Senior Vice President for Clinical Strategy and Chief Medical Officer for UnitedHealthcare.

    Dr. Pronovost was elected to the National Academy of Medicine in 2011, to the American Academy of Nursing, and has received multiple honorary degrees. He is an advisor to the World Health Organization’s World Alliance for Patient Safety and regularly addresses the U.S. Congress on patient safety issues. He is a founder of VisICU, a tele ICU company purchased by Philips; and Doctella, a health information platform for remote patient monitoring purchased by Masimo. He is a strategic advisor for several healthcare technology and venture capital companies. Today, he is known as one of the most influential executives and physician leaders in healthcare and one of the Top 25 innovators in healthcare.

    Sarah Knowles, DNP, APRN, ACCNS-AG, GERO-BC, WCC

    Principal Project Manager, Quality Institute; Co-Chair Research and Innovation Council; UH Well-Being Ambassador

    University Hospitals Cleveland Medical Center

    Sarah Knowles, DNP, APRN, ACCNS-AG, GERO-BC, WCC, has worked at University Hospitals since 2006 and is currently a Principal Project Manager in the Quality Institute. In her grant funded role she has overseen the development and implementation of two system wide quality improvement initiatives – Learning from Defects (LFDs) and Peer to Peer Learning (P2P). Through the creation of these two programs, she has demonstrated her ability to lead groups of various sizes through change as they strive towards both process and practice improvement. Dr. Knowles has a long tenure of working with nurses at all levels in professional development activities. She is a respected clinical nurse specialist specializing in the adult and geriatric populations. Her research has focused on staff nurse acceptance and use of continuous vital signs monitoring (CVSM). She holds certifications as an adult/gero clinical nurse specialist in wellness through acute care, gerontological nursing, and wound care.

    Dr. Knowles received her BSN from the University of Toledo, her MSN with a focus in Nursing Education from Cleveland State University, her post master’s certificate as a clinical nurse specialist from Kent State University, and her DNP from Ursuline College.

    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

    Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.